A Q&A with ‘Rising Leader’ Therese Liechtenstein

In an interview with In Vivo, ‘Rising Leader’ Therese Liechtenstein, investment director in the biotechnology team at M Ventures, discusses the current trends in biotech VC, and why she’s “always been interested in the intersection of biology and business”.

Therese has always enjoyed the crossover between exciting science and the entrepreneurial and financial frameworks that allow it to take place.  At M Ventures, Therese plays an integral part in the creation and financing of multiple companies in the M Ventures portfolio, guiding them towards key value inflection points that a potential partner or acquirer would like to see.

Therese was selected as one of the top 30 Rising Leaders in the 3rd annual listing of In Vivo’s ‘Rising Leaders’ 2022.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH